FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979354706> ?p ?o ?g. }

• W2979354706 endingPage "5270" @default.
• W2979354706 startingPage "5270" @default.
• W2979354706 abstract "Abstract Introduction Acute lymphoblastic leukemia (ALL) is the most frequent cancer in childhood, but treatments' progress now allowsto obtain prolonged remission or curein over 90% of the patients. Consequently, therapeutic de-escalation is now an objective for future treatment protocols, providing that biomarkers allow to reliablyidentifygood responders. Among such indicators, low levels of Minimal Residual Disease (MRD) obtained early after induction chemotherapy stand out as good candidates. The latter can be investigated usingmultiparameterflow cytometry (MFC) or real-time polymerase chain reaction (RT-PCR) for immunoglobulins or T-cell receptors (IG TCR) rearrangements. In this study we report the impact on survival of two early points of peripheral blood (PB) MRD assessment by MFC at days 8 and 15 on a cohort of 125 children with B-ALL enrolled in the French FRALLE trial and compared to molecular MRD in the bone marrow (BM) at day 35. Patients and methods. The study enrolled 67 boys and 58 girls and the duration of the study allowed for a median follow up of 52,1months. Median age at diagnosis was 57 months old (range 18 to 196), 101 children were between 1 to 10 years old and 24 were older than 10. Complete blood counts (CBC) at diagnosis showed a median of 6.7x109/L leucocytes (range 0.47 - 151x109/L) and 33% blasts (range 0 to 97%). One hundred and eight children had less than 50x109/L leucocytes while 17 had higher counts. EGIL classification at diagnosis allowed to classify patients as three B-I, 94 B-II, 27 B-III and 1 B-IV. Cytogenetic analyses were performed for 118 patients who were partitioned as follows: low risk n=47, intermediate risk n=55 and high risk n=16 (Harrisson CJ et al., BJH, 2010). Eighty-three patients were in the low risk group and 42 in the high-risk group as described by the FRALLE protocol. Seven patients of the 64 tested had an IKZF1 deletion. During the duration of the study, 20 patients relapsed and 8 died. Corticosensitivitywas defined by less than 1x109/L PB blasts on day 8 andchemosensitivity by less than 5% BM blasts on day 21 on BM smears. PB MRD was assessed in MFC with a single five or ten colors tube adapted to each patient's leukemia associatedimmunophenotypeon a backbone of CD45, CD19, CD10 and CD38. Statistical analyzes examined factors impacting disease-free survival (DFS) using Log rank test and Kaplan-Meier using theMedcalc® software (Ostend, Belgium). P values <0.05 were considered significant. Results None of diagnosis features had any significant impact on DFS: age (p=0,95), risk group (p=0,17), EGIL classification (p=0,55), cytogenetics (p= 0,87), leucocyte count (p=0,36) nor IKZF1 deletion (p=0,2). Of the 125 patients, 9 were corticoresistant, 79 corticosensitive and 37 not evaluable because of less than 1x109/L leucocyte at diagnosis.Corticosensitivity had no impact on DFS (p=0,11). Conversely,chemosensitivity had a significant positive impact on DFS (p= 0,009). Day 8 PB MRD did not oultlineany significantly different DFS, whether considering detectable vs undetectable MRD (p=0.65) or MRD levels (logwisefrom >10-1 to <10-4, p=0,22). Conversely, PB MFC at day 15 appeared highly discriminant. Considering notdetectablevs detectable MRD, 4 years DFS was 91,6+3% vs. 67,6+9% p=0,0013 (Figure 1). Further refining the thresholds of MRD logwisedid not modify the significance (p=0.004; Figure 2). Indeed, DFS at 48 months was 61+15 % (n=16) for MRD >10-3, 74+11% ( n=18) for MRD <10-3->10-4 and 92+3% ( n=91) for MRD<10-4. Comparison of PB MFC MRD on day 15 with day 35 BM molecular MRD showed concordance in 72% of the cases (83 negative/negative and 7 positive/positive, 48 months DFS 94.6+2.7% and 38+20% respectively). Eight patients were negative in PB but positive in BM (DFS 62.5+17%).Twenty seven where positive in PB but negative in BM (DFS 83.5+7.6%).These differences were statistically highly significant (p <0.0001). Conclusion This study demonstrates that even in the good prognosis context of childhood ALL, early MRD retains a highly significant prognostic value. It is of importance that this result was obtained not only on day 35 BM but interestingly, even earlier on day 15 PB. This less invasive procedure can easily be applied, especially for children. It should allow to detectgood responders, with MFC MRD levels below 10-4 for whom a de-escalation of chemotherapy could be considered. Conversely, the detection of blasts by MFC in day 15 PB is worrisome. Disclosures No relevant conflicts of interest to declare." @default.
• W2979354706 created "2019-10-18" @default.
• W2979354706 creator A5000858647 @default.
• W2979354706 creator A5020187382 @default.
• W2979354706 creator A5022025860 @default.
• W2979354706 creator A5038457477 @default.
• W2979354706 creator A5040627370 @default.
• W2979354706 creator A5050278979 @default.
• W2979354706 creator A5068303471 @default.
• W2979354706 creator A5091833140 @default.
• W2979354706 date "2016-12-02" @default.
• W2979354706 modified "2023-10-02" @default.
• W2979354706 title "Comparative Value of the Assessment of Minimal Residual Disease in Peripheral Blood at Days 8 and 15 By Flow Cytometry in Childhood Acute Lymphoblastic Leukemia" @default.
• W2979354706 doi "https://doi.org/10.1182/blood.v128.22.5270.5270" @default.
• W2979354706 hasPublicationYear "2016" @default.
• W2979354706 type Work @default.
• W2979354706 sameAs 2979354706 @default.
• W2979354706 citedByCount "0" @default.
• W2979354706 crossrefType "journal-article" @default.
• W2979354706 hasAuthorship W2979354706A5000858647 @default.
• W2979354706 hasAuthorship W2979354706A5020187382 @default.
• W2979354706 hasAuthorship W2979354706A5022025860 @default.
• W2979354706 hasAuthorship W2979354706A5038457477 @default.
• W2979354706 hasAuthorship W2979354706A5040627370 @default.
• W2979354706 hasAuthorship W2979354706A5050278979 @default.
• W2979354706 hasAuthorship W2979354706A5068303471 @default.
• W2979354706 hasAuthorship W2979354706A5091833140 @default.
• W2979354706 hasConcept C126322002 @default.
• W2979354706 hasConcept C203014093 @default.
• W2979354706 hasConcept C2776863199 @default.
• W2979354706 hasConcept C2778461978 @default.
• W2979354706 hasConcept C2779823535 @default.
• W2979354706 hasConcept C2781107101 @default.
• W2979354706 hasConcept C2909962599 @default.
• W2979354706 hasConcept C3017910909 @default.
• W2979354706 hasConcept C46762472 @default.
• W2979354706 hasConcept C553184892 @default.
• W2979354706 hasConcept C71924100 @default.
• W2979354706 hasConceptScore W2979354706C126322002 @default.
• W2979354706 hasConceptScore W2979354706C203014093 @default.
• W2979354706 hasConceptScore W2979354706C2776863199 @default.
• W2979354706 hasConceptScore W2979354706C2778461978 @default.
• W2979354706 hasConceptScore W2979354706C2779823535 @default.
• W2979354706 hasConceptScore W2979354706C2781107101 @default.
• W2979354706 hasConceptScore W2979354706C2909962599 @default.
• W2979354706 hasConceptScore W2979354706C3017910909 @default.
• W2979354706 hasConceptScore W2979354706C46762472 @default.
• W2979354706 hasConceptScore W2979354706C553184892 @default.
• W2979354706 hasConceptScore W2979354706C71924100 @default.
• W2979354706 hasIssue "22" @default.
• W2979354706 hasLocation W29793547061 @default.
• W2979354706 hasOpenAccess W2979354706 @default.
• W2979354706 hasPrimaryLocation W29793547061 @default.
• W2979354706 hasRelatedWork W1505732768 @default.
• W2979354706 hasRelatedWork W1597749264 @default.
• W2979354706 hasRelatedWork W1959531726 @default.
• W2979354706 hasRelatedWork W1969856234 @default.
• W2979354706 hasRelatedWork W2032551026 @default.
• W2979354706 hasRelatedWork W2071244122 @default.
• W2979354706 hasRelatedWork W2352094097 @default.
• W2979354706 hasRelatedWork W2398492191 @default.
• W2979354706 hasRelatedWork W2406056937 @default.
• W2979354706 hasRelatedWork W2485379494 @default.
• W2979354706 hasRelatedWork W2979970847 @default.
• W2979354706 hasRelatedWork W2980117171 @default.
• W2979354706 hasRelatedWork W2980491574 @default.
• W2979354706 hasRelatedWork W2980676315 @default.
• W2979354706 hasRelatedWork W2981221959 @default.
• W2979354706 hasRelatedWork W2993478989 @default.
• W2979354706 hasRelatedWork W3031203270 @default.
• W2979354706 hasRelatedWork W3209132271 @default.
• W2979354706 hasRelatedWork W588946044 @default.
• W2979354706 hasRelatedWork W1658530969 @default.
• W2979354706 hasVolume "128" @default.
• W2979354706 isParatext "false" @default.
• W2979354706 isRetracted "false" @default.
• W2979354706 magId "2979354706" @default.
• W2979354706 workType "article" @default.